111 Receivables

As of the most recent data (March 2026), YI shows a receivables of $260M. That compares with $360M in the prior-year period — down 27.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, YI's receivables is now $260M (was $360M) — a 27.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether 111 is outperforming or lagging.

Tracking YI's receivables over time shows whether 111 is scaling, shrinking, or reshaping that part of the business. The current reading is $260M That compares with $360M in the prior-year period — down 27.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has 111's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $260M) with ownership activity and broader fundamentals.

111's receivables is $260M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.